The high cost of implantable defibrillators

被引:39
作者
Hlatky, Mark A.
Mark, Daniel B.
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Duke Univ, Med Ctr, Durham, NC USA
关键词
cost-effectiveness; implantable defibrillator; sudden death;
D O I
10.1093/eurheartj/ehl311
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Increased use of ICDs in patients with cardiac disease has the potential to strain national health care budgets because of the large numbers of eligible patients and the high cost of the ICDs. Randomized trials show ICDs increase life-expectancy in some groups of patients and also increase total medical costs significantly. ICDs exemplify the rote of new technology as the main force behind rising health care costs. ICDs have not been used in at[ eligible patients, in part because of cost, but also because of patient resistance and a shortage of specialists able to implant and manage complex ICDs. The cost-effectiveness of ICDs would be improved by development of simpler and cheaper devices, and by better tools to identify patients who benefit from an ICD.
引用
收藏
页码:388 / 391
页数:4
相关论文
共 23 条
[1]
The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating medicare beneficiaries [J].
Al-Khatib, SM ;
Lucas, FL ;
Jollis, JG ;
Malenka, DJ ;
Wennberg, DE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (08) :1536-1540
[2]
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[4]
CAMM AJ, EUR HEART J, DOI DOI 10.1093/EURHEARTJ/EHL166
[5]
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials [J].
Connolly, SJ ;
Hallstrom, AP ;
Cappato, R ;
Schron, EB ;
Kuck, KH ;
Zipes, DP ;
Greene, HL ;
Boczor, S ;
Domanski, M ;
Follmann, D ;
Gent, M ;
Roberts, RS .
EUROPEAN HEART JOURNAL, 2000, 21 (24) :2071-2078
[6]
TGhe value of medical spending in the United States, 1960-2000 [J].
Cutler, David M. ;
Rosen, Allison B. ;
Vijan, Sandeep .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) :920-927
[7]
Implantable cardioverter defibrillators in primary and secondary prevention: A systematic review of randomized, controlled trials [J].
Ezekowitz, JA ;
Armstrong, PW ;
McAlister, FA .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (06) :445-452
[8]
Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial [J].
Feldman, AM ;
de Lissovoy, G ;
Bristow, MR ;
Saxon, LA ;
De Marco, T ;
Kass, DA ;
Boehmer, J ;
Singh, S ;
Whellan, DJ ;
Carson, P ;
Boscoe, A ;
Baker, TM ;
Gunderman, MR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (12) :2311-2321
[9]
Primary prophylaxis with the implantable cardioverter-defibrillator - The need for improved risk stratification [J].
Gehi, A ;
Haas, D ;
Fuster, V .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (08) :958-960
[10]
IN PRAISE OF SUDDEN-DEATH [J].
GREENBERG, H .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1982, 382 (MAR) :181-182